Hepcidin levels in diabetes mellitus and polycystic ovary syndrome
Amir H. Sam(Charing Cross Hospital), Kevin G. Murphy(Hammersmith Hospital), Carel W. le Roux(University College Dublin), Dimitris Papamargaritis(University of Leicester), Anjali Amin, Lisa Webber(Singapore General Hospital), Richard Chapman(Imperial College Healthcare NHS Trust), Mark Busbridge(Imperial College Healthcare NHS Trust), Gary Frost(Imperial College London), Norlida Mat Daud(National University of Malaysia), Stephen Franks(Hammersmith Hospital), Michelle Sleeth(Hammersmith Hospital), Davinia White(Hammersmith Hospital), S R Bloom(Hammersmith Hospital), Niamh Martin(Hammersmith Hospital), Nurhafzan A. Ismail(Hammersmith Hospital)
Cited by 77
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
|Nature Communications|2014|1.7k
Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>
|New England Journal of Medicine|2003|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k